Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Rule 8.3 - Flying Brands

3 Oct 2008 09:14

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION \* TName of person dealing (Note 1) River and Mercantile Asset Management---------------------------------------------------------------------------------------------------------Company dealt in Flying Brands UTS---------------------------------------------------------------------------------------------------------Class of relevant security to which the Securities of the offeree company dealings being disclosed relate (Note 2)---------------------------------------------------------------------------------------------------------Date of dealing 02/10/08---------------------------------------------------------------------------------------------------------\* T 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) \* T Long Short-------------------------------------------------------------------------------------------------------- Number (%) Number (%)--------------------------------------------------------------------------------------------------------(1) Relevant securities 2,177,558 8.59%--------------------------------------------------------------------------------------------------------(2) Derivatives (other than options)--------------------------------------------------------------------------------------------------------(3) Options and agreements to purchase/sell--------------------------------------------------------------------------------------------------------Total--------------------------------------------------------------------------------------------------------\* T (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) \* T Class of relevant security: Long Short-------------------------------------------------------------------------------------------------------- Number (%) Number (%)--------------------------------------------------------------------------------------------------------(1) Relevant securities--------------------------------------------------------------------------------------------------------(2) Derivatives (other than options)--------------------------------------------------------------------------------------------------------(3) Options and agreements to purchase/sell--------------------------------------------------------------------------------------------------------Total--------------------------------------------------------------------------------------------------------\* T (c) Rights to subscribe (Note 3) \* TClass of relevant security: Details---------------------------------------------------------------------------------------------------------1 Ord 0.005P---------------------------------------------------------------------------------------------------------\* T 3. DEALINGS (Note 4) (a) Purchases and sales \* TPurchase/sale Number of securities Price per unit (Note 5)---------------------------------------------------------------------------------------------------------Purchase 105,000£0.45---------------------------------------------------------------------------------------------------------\* T (b) Derivatives transactions (other than options) \* TProduct name, Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5)e.g. CFD--------------------------------------------------------------------------------------------------------\* T (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying \* TProduct name, Writing, Number of Exercise Type, e.g. Expiry Option moneye.g. call option selling, securities to price American, date paid/received purchasing, which the option European per unit (Note varying etc. relates (Note 7) etc. 5)-------------------------------------------------------------------------------------------------------\* T (ii) Exercising \* TProduct name, e.g. call option Number of securities Exercise price per unit (Note 5)---------------------------------------------------------------------------------------------------------\* T (d) Other dealings (including new securities) (Note 4) \* TNature of transaction (Note 8) Details Price per unit (if applicable) (Note 5)---------------------------------------------------------------------------------------------------------\* T 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives \* TFull details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.---------------------------------------------------------------------------------------------------------\* T Is a Supplemental Form 8 attached? (Note 9) YES/NO \* TDate of disclosure 03/10/08---------------------------------------------------------------------------------------------------------Contact name Michael Anglim---------------------------------------------------------------------------------------------------------Telephone number 020 7601 6247---------------------------------------------------------------------------------------------------------If a connected EFM, name of offeree/offeror with which connected---------------------------------------------------------------------------------------------------------If a connected EFM, state nature of connection (Note 10)---------------------------------------------------------------------------------------------------------\* T Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk Copyright Business Wire 2008
Date   Source Headline
2nd Sep 20217:00 amRNSBoard Changes
1st Sep 202110:00 amRNSStart of Trading on the OTCQB Venture Market
27th Aug 20219:57 amRNSHalf Yearly Report
11th Jun 20214:41 pmRNSSecond Price Monitoring Extn
11th Jun 20214:36 pmRNSPrice Monitoring Extension
11th Jun 20212:05 pmRNSSecond Price Monitoring Extn
11th Jun 20212:00 pmRNSPrice Monitoring Extension
11th Jun 202111:05 amRNSSecond Price Monitoring Extn
11th Jun 202111:00 amRNSPrice Monitoring Extension
11th Jun 20218:00 amRNSIQAI Awarded “Gad-Free” Patent
4th Jun 20217:00 amRNSIB Software Chosen by LA County Hospital
19th May 202112:06 pmRNSResult of AGM
27th Apr 20213:27 pmRNSNotice of AGM
20th Apr 202110:21 amRNSFinal Results
16th Apr 20214:41 pmRNSSecond Price Monitoring Extn
16th Apr 20214:36 pmRNSPrice Monitoring Extension
13th Apr 20217:27 amRNSIQAI commits to Phase 1 study
6th Apr 20217:00 amRNSFive Year NCI Award Grant to IB
5th Feb 20214:41 pmRNSSecond Price Monitoring Extn
5th Feb 20214:36 pmRNSPrice Monitoring Extension
5th Feb 20212:05 pmRNSSecond Price Monitoring Extn
5th Feb 20212:01 pmRNSPrice Monitoring Extension
5th Feb 20219:05 amRNSSecond Price Monitoring Extn
5th Feb 20219:00 amRNSPrice Monitoring Extension
28th Jan 20217:00 amRNS"Gad Free" Imaging Update
25th Jan 202111:01 amRNSPrice Monitoring Extension
14th Jan 20217:00 amRNSTechnology Portfolio Update
7th Jan 20212:06 pmRNSSecond Price Monitoring Extn
7th Jan 20212:00 pmRNSPrice Monitoring Extension
31st Dec 202012:41 pmRNSSecond Price Monitoring Extn
31st Dec 202012:36 pmRNSPrice Monitoring Extension
31st Dec 202011:00 amRNSPrice Monitoring Extension
10th Dec 202010:41 amRNSDirector Dealing and CLN Conversion - Correction
9th Dec 20202:05 pmRNSSecond Price Monitoring Extn
9th Dec 20202:01 pmRNSPrice Monitoring Extension
9th Dec 20209:02 amRNSDirector Dealing and Conversion of Loan Notes
7th Dec 202011:25 amRNSDirector Dealing
4th Dec 20204:52 pmRNSIssue of shares to Mayo Clinic
3rd Dec 20207:01 amRNSRelease of StoneChecker 20.12
26th Nov 20207:00 amRNSIMAGING BIOMETRICS UPGRADES IB CLINIC™ SOFTWARE
23rd Nov 20204:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20204:36 pmRNSPrice Monitoring Extension
23rd Nov 20202:06 pmRNSSecond Price Monitoring Extn
23rd Nov 20202:00 pmRNSPrice Monitoring Extension
23rd Nov 20201:45 pmRNSLSN Software is now CE Mark Approved
23rd Nov 202011:06 amRNSSecond Price Monitoring Extn
23rd Nov 202011:00 amRNSPrice Monitoring Extension
20th Nov 202011:05 amRNSSecond Price Monitoring Extn
20th Nov 202011:00 amRNSPrice Monitoring Extension
20th Nov 20209:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.